Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Gabrielli

Showing results (141-150 of 288) with videos related to

Pageof 29
Sort By:
Frontiers in Cardiovascular Medicine|July 5, 2021
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.
Giornale Italiano Di Cardiologia (2006)|March 27, 2023
[ANMCO Position paper: Vericiguat use in heart failure: from evidence to place in therapy]Stefania Angela Di Fusco, Alessandro Alonzo, Alberto Aimo, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 22, 2023
ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac deathGiancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 19, 2025
ANMCO statement: semaglutide in the cardio-nephro-metabolic continuumLeonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 22, 2023
ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapyStefania Angela Di Fusco, Alessandro Alonzo, Alberto Aimo, et al.
Clinical Chemistry and Laboratory Medicine|May 23, 2020
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapyAldo Clerico, Daniela Maria Cardinale, Martina Zaninotto, et al.
International Journal of Cardiology|September 2, 2018
Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI studyLeonardo De Luca, Federico Piscione, Furio Colivicchi, et al.
Giornale Italiano Di Cardiologia (2006)|December 23, 2023
[ANMCO/SIMEU Consensus document on the use of reversal agents of antithrombotic therapies in patients with active bleeding or at high-risk of major bleeding events]Leonardo De Luca, Francesco Rocco Pugliese, Beniamino Susi, et al.
Clinical Chemistry and Laboratory Medicine|July 22, 2020
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkersAldo Clerico, Martina Zaninotto, Claudio Passino, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 29, 2017
ANMCO/SIT Consensus Document: telemedicine for cardiovascular emergency networksPasquale Caldarola, Michele Massimo Gulizia, Domenico Gabrielli, et al.
Pageof 29

Showing results (141-150 of 288) with videos related to

Sort By:
Pageof 29
Frontiers in Cardiovascular Medicine|July 5, 2021
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.
Giornale Italiano Di Cardiologia (2006)|March 27, 2023
[ANMCO Position paper: Vericiguat use in heart failure: from evidence to place in therapy]Stefania Angela Di Fusco, Alessandro Alonzo, Alberto Aimo, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 22, 2023
ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac deathGiancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 19, 2025
ANMCO statement: semaglutide in the cardio-nephro-metabolic continuumLeonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 22, 2023
ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapyStefania Angela Di Fusco, Alessandro Alonzo, Alberto Aimo, et al.
Clinical Chemistry and Laboratory Medicine|May 23, 2020
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapyAldo Clerico, Daniela Maria Cardinale, Martina Zaninotto, et al.
International Journal of Cardiology|September 2, 2018
Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI studyLeonardo De Luca, Federico Piscione, Furio Colivicchi, et al.
Giornale Italiano Di Cardiologia (2006)|December 23, 2023
[ANMCO/SIMEU Consensus document on the use of reversal agents of antithrombotic therapies in patients with active bleeding or at high-risk of major bleeding events]Leonardo De Luca, Francesco Rocco Pugliese, Beniamino Susi, et al.
Clinical Chemistry and Laboratory Medicine|July 22, 2020
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkersAldo Clerico, Martina Zaninotto, Claudio Passino, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 29, 2017
ANMCO/SIT Consensus Document: telemedicine for cardiovascular emergency networksPasquale Caldarola, Michele Massimo Gulizia, Domenico Gabrielli, et al.
Pageof 29